Muhammad Aron Pase. Tirzepatide: Dual GIP/GLP-1 Receptor Agonists, from Molecular to Clinical Practice for Treating Type-2 Diabetes and Obesity. InaJEMD. 2024;1(2):96-110. doi:10.66266/inajemd.v1i2.23